UniProtKB/SwissProt variant VAR

Variant information

Variant position:

835

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Threonine (T) to Methionine (M) at position 835 (T835M, p.Thr835Met).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from medium size and polar (T) to medium size and hydrophobic (M)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-1

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In AD; associated with susceptibility to late-onset disease; increased susceptibility to neuronal cell death.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs137875858 [ dbSNP | Ensembl ]

Sequence information

Variant position:

835

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

931

The length of the canonical sequence.

Location on the sequence:

VSEEPTGIDLPLLDPANTIT T VTGPSAFSIPLPIRQKLCSS

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         VSEEPTGIDLPLLDPANTITTVTGPSAFSIPLPIRQKLCSS

Mouse                         VSEEPTGIDLPLLDPASTITTVTGPSAFSIPLPIRQKLCSS

Rat                           VSEEPTGIDLPLLDPASTITTVTGPSAFSIPLPIRQKLCSS

Chicken                       VSEEPTGIDYPIMDSAGSITTIVGPNAFSIPLPIRQKLCSS

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	41 – 931	Netrin receptor UNC5C
Topological domain	402 – 931	Cytoplasmic
Region	402 – 931	Required for netrin-mediated axon repulsion of neuronal growth cones
Alternative sequence	579 – 931	Missing. In isoform 2.

Literature citations

A rare mutation in UNC5C predisposes to late-onset Alzheimer's disease and increases neuronal cell death.
Wetzel-Smith M.K.; Hunkapiller J.; Bhangale T.R.; Srinivasan K.; Maloney J.A.; Atwal J.K.; Sa S.M.; Yaylaoglu M.B.; Foreman O.; Ortmann W.; Rathore N.; Hansen D.V.; Tessier-Lavigne M.; Mayeux R.; Pericak-Vance M.; Haines J.; Farrer L.A.; Schellenberg G.D.; Goate A.; Behrens T.W.; Cruchaga C.; Watts R.J.; Graham R.R.;
Nat. Med. 20:1452-1457(2014)
Cited for: SUBCELLULAR LOCATION; TISSUE SPECIFICITY; INVOLVEMENT IN AD; VARIANT AD MET-835; CHARACTERIZATION OF VARIANT AD MET-835;

An Alzheimer Disease-linked Rare Mutation Potentiates Netrin Receptor Uncoordinated-5C-induced Signaling That Merges with Amyloid beta Precursor Protein Signaling.
Hashimoto Y.; Toyama Y.; Kusakari S.; Nawa M.; Matsuoka M.;
J. Biol. Chem. 291:12282-12293(2016)
Cited for: INTERACTION WITH DAPK1; CHARACTERIZATION OF VARIANT AD MET-835;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot O95185: Variant p.Thr835Met